ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways

Li, Juan-min; Deng, Hai-shan; Yao, Yun-da; Wang, Wei-ting; Hu, Jia-qin; Dong, Yan; Wang, Pei-xun; Liu, Liang; Liu, Zhong-qiu*; Xie, Ying*; Lu, Lin-lin*; Zhou, Hua*广东省人民医院; 广州中医药大学; y
Acta Pharmacologica Sinica2023-12DOI: 10.1038/s41401-023-01124-4
2被引5阅读
引用收藏
分享

摘要

Sinomenine (SIN) is an isoquinoline alkaloid isolated from Sinomenii Caulis, a traditional Chinese medicine used to treat rheumatoid arthritis (RA). Clinical trials have shown that SIN has comparable efficacy to methotrexate in treating patients with RA but with fewer adverse effects. In this study, we explored the anti-inflammatory effects and therapeutic targets of SIN in LPS-induced RAW264.7 cells and in collagen-induced arthritis (CIA) mice. LPS-induced RAW264.7 cells were pretreated with SIN (160, 320, 640 & mu;M); and CIA mice were administered SIN (25, 50 and 100 mg & BULL;kg(-1)& BULL;d(-1), i.p.) for 30 days. We first conducted a solvent-induced protein precipitation (SIP) assay in LPS-stimulated RAW264.7 cells and found positive evidence for the direct binding of SIN to guanylate-binding protein 5 (GBP5), which was supported by molecular simulation docking, proteomics, and binding affinity assays (K-D = 3.486 & mu;M). More importantly, SIN treatment markedly decreased the expression levels of proteins involved in the GBP5/P2X7R-NLRP3 pathways in both LPS-induced RAW264.7 cells and the paw tissue of CIA mice. Moreover, the levels of IL-1 & beta;, IL-18, IL-6, and TNF-& alpha; in both the supernatant of inflammatory cells and the serum of CIA mice were significantly reduced. This study illustrates a novel anti-inflammatory mechanism of SIN; SIN suppresses the activity of NLRP3-related pathways by competitively binding GBP5 and downregulating P2X7R protein expression, which ultimately contributes to the reduction of IL-1 & beta; and IL-18 production. The binding specificity of SIN to GBP5 and its inhibitory effect on GBP5 activity suggest that SIN has great potential as a specific GBP5 antagonist.

学科与关键词

关键词
rheumatoid arthritissinomenineGBP5NLRP3RAW2647 cells
相关
加载中…
  • Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review
    Li, Juan -Min; Yao, Yun-Da; Luo, Jin-Fang; Liu, Jian-Xin; Liu, Zhong-Qiu; Dong, Yan*; Xie, Ying*; Zhou, Hua*PHYTOMEDICINE, 2023, 121: 155114.
  • The Correlation Between Decreased Ornithine Level and Alleviation of Rheumatoid Arthritis Patients Assessed by a Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sinomenine
    Shi, Ying; Pan, Hu-Dan; Wu, Jian-Lin; Zou, Qing-Hua; Xie, Xin-Yi; Li, Hong-Gang; Zhou, Hua; Bian, Xi-Qing; Leng, Wen-Fei; Wang, Can-Jian; Wang, Ya-Feng; Fang, Yong-Fei*; Liu, Liang*Engineering, 2022, 16: 93-99.被引 4
  • IDENTIFICATION OF NEW BIOMARKERS FOR SINOMENINE TREATMENT IN RHEUMATOID ARTHRITIS BASED ON BIOINFORMATICS ANALYSIS
    Shen, X.; Yanqun, L.; Guo, X.; Linfeng, W.; Zhang, J.; Feng, Z.
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Pharmacologica Sinica
发表日期
2023-12
卷期
第 44 卷, 第 12 期
页码
2504-2524
DOI
10.1038/s41401-023-01124-4
语言
ENGLISH
期刊收录
CAST-P
成果收录
SCIE
资助标注
Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao of National Natural Science Fund of China [81929003, 81628016]; 2020 Hunan Province Science and Technology Innovation Key Projects [2020SK1020]; Sanming Project of Medicine in Shenzhen, Guangdong Province, China [SZZYSM202111002]

作者

  • L

    Li, Juan-min (第一作者)

    guangzhou univ chinese med

  • D

    Deng, Hai-shan

    guangzhou univ chinese med

查看全部 12 位作者收起作者
  • Y

    Yao, Yun-da

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wang, Wei-ting

    guangzhou univ chinese med

  • H

    Hu, Jia-qin

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • D

    Dong, Yan

    guangzhou univ chinese med

  • W

    Wang, Pei-xun

    guangzhou univ chinese med

  • L

    Liu, Liang

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Zhong-qiu (通讯)

    guangzhou univ chinese med

  • X

    Xie, Ying (通讯)

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • L

    Lu, Lin-lin (通讯)

    guangzhou univ chinese med

  • Z

    Zhou, Hua (通讯)

    guangzhou univ chinese med · 2 · guangdong prov acad chinese med sci · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417